Ping Chi, MD, PhD

About Me

I am a physician-scientist and a board-certified medical oncologist who works closely with our multidisciplinary team caring for patients with soft tissue and bone sarcomas, and melanomas.  My research focus is on the pathogenesis and treatment of sarcomas. I am involved in a multidisciplinary effort with oncologists, pathologist, and surgeons to analyze tumor tissues and to develop clinical trials tailored to personalized therapy. My laboratory in the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center focuses on the study of critical genetic and epigenetic “drivers” and development of novel biomarkers and therapeutics in sarcomas, in particular GIST and MPNST,  using cell, tissue and mouse models.

I am fluent in English and Mandarin.

  • Clinical Expertise: Sarcomas of Soft Tissue and Bone; GIST
  • Languages Spoken: English; Chinese
  • Education: MD, Cornell University Medical College
  • Residencies: Internal Medicine - Brigham and Women's Hospital
  • Fellowships: Medical Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.